These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17344922)

  • 1. Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D(3)).
    Molnár I; Stark N; Lovato J; Powell BL; Cruz J; Hurd DD; Mathieu JS; Chen TC; Holick MF; Cambra S; McQuellon RP; Schwartz GG
    Leukemia; 2007 May; 21(5):1089-92. PubMed ID: 17344922
    [No Abstract]   [Full Text] [Related]  

  • 2. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
    Leventis P; Kiely PD
    Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 [1 alpha(OH)D3]].
    Irino S; Taoka T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1183-90. PubMed ID: 2837981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life and brain function following high-dose recombinant human erythropoietin in low-risk myelodysplastic syndromes: a preliminary report.
    Clavio M; Nobili F; Balleari E; Girtler N; Ballerini F; Vitali P; Rosati P; Venturino C; Varaldo R; Gobbi M; Ghio R; Rodriguez G
    Eur J Haematol; 2004 Feb; 72(2):113-20. PubMed ID: 14962248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical application of retinoic acid and vitamin D3 derivatives to the treatment of refractory anemias].
    Yoshida Y
    Nihon Rinsho; 1993 Apr; 51(4):1023-8. PubMed ID: 8387118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vitamin D supplementation in institutionalized elderly. Effects of vitamin D3 (100,000 IU) orally administered every 3 months on serum levels of 25-hydroxyvitamin D].
    Zeghoud F; Jardel A; Garabedian M; Salvatore R; Moulias R
    Rev Rhum Mal Osteoartic; 1990 Nov; 57(11):809-13. PubMed ID: 1963239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated PTH levels in hypovitaminosis D are more rapidly suppressed by the administration of 1,25-dihydroxy-vitamin D3 than by vitamin D3.
    Theiler R; Bischoff H; Tyndall A; Stähelin HB
    Int J Vitam Nutr Res; 1998; 68(1):36-41. PubMed ID: 9503046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia.
    Collins N; Maher J; Cole M; Baker M; Callaghan N
    Q J Med; 1991 Feb; 78(286):113-22. PubMed ID: 1851568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D(2) analog (Paricalcitol; Zemplar) for treatment of myelodysplastic syndrome.
    Koeffler HP; Aslanian N; O'Kelly J
    Leuk Res; 2005 Nov; 29(11):1259-62. PubMed ID: 16164982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of MDS with special reference to the effects of androgen on ineffective erythropoiesis.
    Mitsutani S
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1455-60. PubMed ID: 2854695
    [No Abstract]   [Full Text] [Related]  

  • 11. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation.
    Jean G; Souberbielle JC; Chazot C
    Nephrol Dial Transplant; 2009 Dec; 24(12):3799-805. PubMed ID: 19622574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correcting poor vitamin D status: do older adults need higher repletion doses of vitamin D3 than younger adults?
    Whiting SJ; Calvo MS
    Mol Nutr Food Res; 2010 Aug; 54(8):1077-84. PubMed ID: 20440693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D Status in Israeli subjects before the initiation and after the cessation of vitamin D supplements.
    Saliba W; Barnett O; Rennert HS; Lavi I; Rennert G
    Calcif Tissue Int; 2011 Nov; 89(5):419-25. PubMed ID: 21964950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases.
    Amir E; Simmons CE; Freedman OC; Dranitsaris G; Cole DE; Vieth R; Ooi WS; Clemons M
    Cancer; 2010 Jan; 116(2):284-91. PubMed ID: 19918922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D supplementation in a nursing home population.
    Schwalfenberg GK; Genuis SJ
    Mol Nutr Food Res; 2010 Aug; 54(8):1072-6. PubMed ID: 20440692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial.
    Moreira-Pfrimer LD; Pedrosa MA; Teixeira L; Lazaretti-Castro M
    Ann Nutr Metab; 2009; 54(4):291-300. PubMed ID: 19729890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecalciferol supplements improve vitamin D deficiency in renal transplant recipients.
    Jiménez Álvaro S; Marcén R; Villacorta J; Fernández-Rodríguez A; Galeano C; Villafruela JJ; Teruel JL; Burgos FJ; Quereda C
    Transplant Proc; 2010 Oct; 42(8):2921-3. PubMed ID: 20970571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome.
    Spiriti MA; Latagliata R; Niscola P; Cortelezzi A; Francesconi M; Ferrari D; Volpe E; Clavio M; Grossi A; Reyes MT; Musto P; Mitra ME; Azzarà A; Pagnini D; D'Arena G; Spadano A; Balleari E; Pecorari P; Capochiani E; De Biasi E; Perego D; Monarca B; Pisani F; Scaramella G; Petti MC
    Ann Hematol; 2005 Mar; 84(3):167-76. PubMed ID: 15592833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
    Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
    Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes.
    Tamburini J; Elie C; Park S; Beyne-Rauzy O; Gardembas M; Berthou C; Mahe B; Sanhes L; Stamatoullas A; Vey N; Aouba A; Slama B; Quesnel B; Vekhoff A; Sotto JJ; Vassilief D; Al-Nawakil C; Fenaux P; Dreyfus F; Bouscary D;
    Leuk Res; 2009 Apr; 33(4):547-50. PubMed ID: 18640718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.